| PR | by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr... |
|---|---|
| IMR | Infant Mortality Rate; 영아 사망률 |
| CMR | cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c... |
| NMR | neonatal mortality rate; nictitating membrane response; nuclear magnetic resonance |
| RSMR | relative standard mortality rate |
| maternal deprivation | Prolonged separation of the offspring from the mother. (12 Dec 1998) |
|---|---|
| maternal deprivation syndrome | <syndrome> A failure to thrive seen in infants and young children and exhibited as a constellation of physical signs, symptoms, and behaviours, usually associated with maternal loss, absence or neglect, and characterised by lack of responsiveness to the environment and often depression. (05 Mar 2000) |
| maternal dystocia | Dystocia caused by an abnormality or physical problem in the mother. (05 Mar 2000) |
| maternal effect gene | Gene, usually required for early embryonic development, whose product is secreted into the egg by the mother. The phenotype is thus determined by the mother's, rather than the egg's, genotype. Compare:. Zygotic effect gene. See: egg polarity gene. (18 Nov 1997) |
| maternal exposure | Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure. (12 Dec 1998) |
| maternal-foetal exchange | Exchange of substances between the maternal blood and the foetal blood through the placental barrier. It excludes microbial or viral transmission. (12 Dec 1998) |
| maternal health services | Organised services to provide health care to expectant and nursing mothers. (12 Dec 1998) |
| maternal immunity | <epidemiology> Immunity for a neonate provided by IgG antibody generated by a mother and passed across the placenta to the unborn offspring. This provides short lived protection (with a typical half life of 3-6 months) to the neonate. Also known as immunity. (05 Dec 1998) |
| maternal inheritance | Inheritance through the maternal cell line, for example through the oocyte and eggs. Mitochondrial genes are maternally inherited and various other nonMendelian forms of inheritance may also appear as maternal inheritance. (18 Nov 1997) |
| maternal mRNA | <molecular biology> Messenger RNA found in oocytes and early embryos that is derived from the maternal genome during oogenesis. See: masked messenger RNA. (18 Nov 1997) |
| maternal placenta | <anatomy> The part of the placenta derived from the uterine tissue. See: placenta. Synonym: maternal placenta, placenta uterina. (05 Mar 2000) |
| maternal serum alpha-fetoprotein | A plasma protein, alpha-fetoprotein (afp) is normally produced by the foetus. The level of afp in the blood serum of pregnant women provides a screening test for open neural tube defects (anencephaly and spina bifida) and for down syndrome (and other chromosome abnormalities). The maternal serum afp (msafp) tends to be unusally high with open neural tube defects and unsually low with down syndrome. (12 Dec 1998) |
| maternal welfare | Organised efforts by communities or organizations to improve the health and well-being of the mother. (12 Dec 1998) |
| phenylketonuria, maternal | Phenylketonuria in a pregnant woman. The maternal disease puts the foetus at great risk of mental retardation and other congenital diseases. (12 Dec 1998) |
| direct maternal death | Death resulting from obstetric complications of the gestation, labour, or puerperium, and from interventions, omissions, incorrect treatment, or a chain of events caused by any of the above, indirect maternal death, an obstetric death resulting from previously existing disease or from disease developing during pregnancy, labour, or the puerperium; it is not directly due to obstetric causes, but to conditions aggravated by the physiological effects of pregnancy. (05 Mar 2000) |